Search Results

Bariatric surgery found to be more effective than GLP-1 drugs in reducing kidney disease progression, according to a recent study. (Representational image: Wikimedia Commons)
Ankur Deka
3 min read
Study finds bariatric surgery significantly reduces risk of chronic kidney disease progression compared to GLP-1 drugs in patients with obesity and diabetes
After extensive review, the MHRA concludes no link between popular diabetes drugs like Wegovy and mental health concerns. (Wikimedia Commons)
Ankur Deka
2 min read
MHRA concludes there is no evidence to support a connection between GLP-1 receptor agonists, including Novo Nordisk's Wegovy, and suicide-related risks
Several GLP-1 receptor agonists are available on the market, including exenatide (Byetta), liraglutide (Victoza), dulaglutide (Trulicity), and semaglutide (Ozempic). (Representational Image: Unsplash)
MBT Desk
4 min read
Explore the side effects of GLP-1 drugs, used for managing type 2 diabetes, including gastrointestinal issues, hypoglycemia, pancreatitis, and more
With the skyrocketing popularity of weight-loss drugs like Ozempic, Wegovy, and Mounjaro, health experts are noticing an increasing trend of use among younger Americans. 
(Representational Image: Pixabay)
MBT Desk
3 min read
Parents Should be more Careful : Insights from Doctors on Youthful Usage of these Drugs and Health Risks
Kourtney Kardashian's latest venture in weight management has led to the creation of a supplement marketed as a "natural GLP-1" alternative, designed to help with weight loss without any side effects—at least, according to her claims. (Representational image: Unsplash)
MBT Desk
3 min read
Kourtney Kardashian's Lemme GLP-1 supplement is marketed for weight loss, but experts question its connection to GLP-1 hormones and warn of potential side effects
GLP-1 Receptor Agonist Shortage Causes Severe Problems for Diabetes Patients (Representational image: Unsplash )
MBT Desk
5 min read
Use of GLP-1 Receptor Agonists for Weight Loss Leads to Shortages for Diabetes Patients
Read More
logo
Medbound
www.medboundtimes.com